ROSG Related Corporate News
-
Rosetta Genomics (ROSG) Higher After Credentialing Agreement w/Prime Health
-
Sanra Pays Full Settlement to Rosetta (ROSG)
-
Rosetta Genomics (ROSG) Enters Settlement with Sanra Labs
-
Rosetta Genomics (ROSG) Receives Two U.S. Patents for microRNAs, miRNAs
-
Rosetta Genomics (ROSG) Highlights Study on MicroRNA Expression
-
Rosetta Genomics (ROSG), PTI Launch miRview mets2 Assay in U.S. Market
-
Rosetta Genomics (ROSG) Hires Three New Execs, Expands Commercial Ops
-
Rosetta Genomics (ROSG) Closes 5.5M Offering at $5/Share
-
Rosetta Genomics (ROSG) Prices 5.5M Common Offering at $5/Share
-
Rosetta Genomics (ROSG), Precision Therapeutics Enter miRview Co-Marketing Agreement
-
Rosetta Genomics (ROSG) Finalizes Termination of IP Agreement with Avatao Biotech
-
Rosetta Genomics (ROSG) Pops on New Patent for Liver Cancer
-
Rosetta Genomics (ROSG) Reports Publication of Data from miRview Lung Assay
-
Rosetta Genomics (ROSG) Announces NY State Approval for miRview Lung
-
Rosetta Genomics (ROSG) Pays Off Secured Loan, Reclaims Unencumbered Rights to Assets
-
Rosetta Genomics (ROSG) Secures Medicare Reimbursement Pricing for miRv
-
Rosetta Genomics (ROSG) to Present miRview Data at Upcoming ASCO Meeting
-
Rosetta Genomics (ROSG) Says Medicare Admin to Cover miRview Mets Assay
-
Rosetta Genomics (ROSG) Gets Key U.S. Patent for miR-378 Composition
-
Rosetta Genomics (ROSG) Enters $1.75M Debt Placement, Possible $1.25M License Agreement
-
Rosetta (ROSG) Sells Majority Rosetta Green Stake in $2.9M Deal
-
Rosetta Genomics (ROSG) Gets miRview Mets Approval in NY
-
Rosetta Genomics (ROSG) Announces Restructuring Aimed at Reducing Cash Burn; to Cut 35 Jobs from Workforce
-
Rosetta Genomics (ROSG) Enters License to Market miRview mets in China
-
Rosetta Genomics (ROSG) trading halted to announce: an exclusive license with Avatao Biotech for distribution of miRview tests in China
-
Rosetta Genomics (ROSG) Satisfies NASDAQ Listing Terms
-
Rosetta Genomics (ROSG) Receives Listing Extension from NASDAQ
-
Rosetta Genomics (ROSG) Signs Additional microRNA Development Agreements
-
Rosetta Genomics (ROSG) Receives Clincial Lab Permit from NYS DOH
-
Rosetta Genomics (ROSG) Announces Reduction of Pay, Elimination of Positions; Will Reduce Monthly Burn Rate by 32%
-
Rosetta Genomics (ROSG) MicroRNA Article Published on Online Version of The Journal of Molecular Diagnostics
-
Rosetta Genomics (ROSG) Announces Formation of Subsidiary, Rosetta Green
-
Rosetta Genomics (ROSG) Increases Ease of miRview Squamous Test Usage
-
Rosetta Genomics (ROSG) Announces Publication of miRview Mets Micro-RNA Test
-
Rosetta Genomics (ROSG) Mesothelioma Joint Study with NYU Langone Med Center To Be Published
-
Rosetta Genomics (ROSG) Gets Claims for Two microRNA Patents
-
Rosetta Genomics (ROSG) Completes Direct Offering for Net Proceeds of $4.5M
-
Rosetta Genomics (ROSG) to Sell Ordinary Shares, Warrants for Net Proceeds of $4.5M
-
Rosetta Genomics (ROSG) Announces that miRview IDs Small-Cell Lung Cancer with High Accuracy
-
Rosetta Genomics (ROSG) and Super Religare Laboratories Sign Exclusive Distribution Agreement
-
Prometheus Labs, Rosetta Genomics (ROSG) Announce Execution of License and Collaboration Agreement
-
Rosetta Genomics (ROSG) and Collaborators Unveil Colon Cancer Screening Diagnostic
-
M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' (ROSG) MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
-
Rosetta Genomics (ROSG) Announces Plans to Recruit a New CFO
Back to ROSG Stock Lookup
